Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:25:33.585Z.
Calculation as of: 2026-10-06T13:25:33.585Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6c02d81e284155bdcda1783dec911e9c0a395e203238f61c1cccf60d236910ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Axsome Therapeutics, Inc.
Market Cap
$9.11B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.04B
Free Cash Flow Yield
N/A
TTM Avg
3.13%
3Y Avg
3.14%
5Y Avg
3.14%
Market Cap
$9.35B
Free Cash Flow Yield
1.00%
TTM Avg
0.10%
3Y Avg
0.11%
5Y Avg
0.11%
Market Cap
$8.78B
Free Cash Flow Yield
N/A
TTM Avg
1.96%
3Y Avg
1.96%
5Y Avg
2.23%
Market Cap
$9.60B
Free Cash Flow Yield
5.62%
TTM Avg
4.93%
3Y Avg
5.16%
5Y Avg
5.30%
Market Cap
$8.59B
Free Cash Flow Yield
1.71%
TTM Avg
2.01%
3Y Avg
2.01%
5Y Avg
2.01%
Market Cap
$9.72B
Free Cash Flow Yield
0.97%
TTM Avg
0.80%
3Y Avg
1.68%
5Y Avg
1.69%
Market Cap
$8.41B
Free Cash Flow Yield
51.57%
TTM Avg
27.78%
3Y Avg
23.52%
5Y Avg
21.02%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $9.11B | N/A | N/A | N/A | N/A |
| Kymera Therapeutics, Inc. (KYMR)vs › | $9.04B | N/A | 3.13% | 3.14% | 3.14% |
| Bruker Corporation (BRKRP)vs › | $9.35B | 1.00% | 0.10% | 0.11% | 0.11% |
| Insulet Corp. (PODD)vs › | $9.39B | 3.18% | 2.73% | 1.80% | 1.80% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | N/A | 1.96% | 1.96% | 2.23% |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 5.62% | 4.93% | 5.16% | 5.30% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 1.71% | 2.01% | 2.01% | 2.01% |
| Bruker Corporation (BRKR)vs › | $9.72B | 0.97% | 0.80% | 1.68% | 1.69% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 51.57% | 27.78% | 23.52% | 21.02% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.87B | 2.61% | 2.45% | 2.48% | 2.48% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
